Medtronic PLC
(NYSE : MDT)

( )
MDT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-1.01%96.040.6%$490.15m
ABTAbbott Laboratories
-1.08%67.680.8%$292.97m
ISRGIntuitive Surgical, Inc.
0.00%558.662.4%$252.54m
TMOThermo Fisher Scientific Inc.
0.42%239.511.0%$245.42m
ALGNAlign Technology, Inc.
0.43%380.016.3%$227.02m
BAXBaxter International Inc.
-0.80%77.071.7%$208.34m
BSXBoston Scientific Corporation
-0.32%37.271.1%$205.24m
BDXBecton, Dickinson and Company
-1.30%257.241.1%$203.68m
SYKStryker Corporation
-0.39%169.841.3%$169.27m
ABMDABIOMED, Inc.
0.58%371.033.3%$166.63m
TNDMTandem Diabetes Care, Inc.
-0.95%39.804.1%$141.16m
EWEdwards Lifesciences Corporation
-1.14%146.301.2%$133.35m
DXCMDexCom, Inc.
0.01%137.948.5%$126.88m
ZBHZimmer Biomet Holdings, Inc.
-0.40%129.551.7%$126.67m
XRAYDENTSPLY International Inc.
-0.83%38.103.0%$103.98m

Company Profile

Medtronic Plc is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist of three divisions: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group segment comprises of three divisions: Surgical Innovations and Respiratory, Gastrointestinal, and Renal. The Restorative Therapies Group contains four divisions: Spine, Brain, Specialty Therapies, and Pain Therapies. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded on January 26, 2015 and is headquartered in Dublin, Ireland.